Variant report

Variant	esv3523695
Chromosome Location	chr10:54782396-54790044
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:54782310..54784916-chr10:54787401..54789318,3	MCF-7	breast:
2	chr10:54782310..54784916-chr10:54787401..54789318,3	MCF-7	breast:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MBL2-2	chr10:54785024-54785887	XLOC_008826
2	lnc-MBL2-2	chr10:54789671-54789855	XLOC_008826
3	lnc-MBL2-2	chr10:54789652-54790030	XLOC_008826
4	lnc-MBL2-2	chr10:54782584-54782720	NONHSAT013446
5	lnc-MBL2-2	chr10:54782584-54782768	XLOC_008826
6	lnc-MBL2-2	chr10:54789671-54789884	XLOC_008826
7	lnc-MBL2-2	chr10:54782584-54782720	XLOC_008826
8	lnc-MBL2-2	chr10:54782584-54782720	XLOC_008826
9	lnc-MBL2-2	chr10:54789671-54789810	NONHSAT013446

No data

Variant related genes	Relation type
MYB	miRNA target sites

Extended variants
information (count: 299 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:299 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546830368	chr10:54782402-54782403	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs73349812	chr10:54782403-54782404	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs193239847	chr10:54782436-54782437	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs572302718	chr10:54782439-54782440	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs67933307	chr10:54782514-54782515	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs58584281	chr10:54782516-54782517	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs538902738	chr10:54782528-54782529	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs374044287	chr10:54782546-54782547	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs552369802	chr10:54782560-54782561	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs569404371	chr10:54782561-54782562	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs538032402	chr10:54782631-54782632	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs555078856	chr10:54782709-54782710	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs568459592	chr10:54782716-54782717	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs560235555	chr10:54782722-54782723	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs150558480	chr10:54782732-54782733	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs139648058	chr10:54782748-54782749	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs117347328	chr10:54782765-54782766	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs183956415	chr10:54782771-54782772	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs187766635	chr10:54782809-54782810	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs558553526	chr10:54782828-54782829	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs575432522	chr10:54782856-54782857	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs192345707	chr10:54782879-54782880	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs561082942	chr10:54782897-54782898	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs12360030	chr10:54782940-54782941	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs543774386	chr10:54782977-54782978	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs77176710	chr10:54782994-54782995	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs368835747	chr10:54783010-54783011	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs563515234	chr10:54783014-54783015	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs184633780	chr10:54783033-54783034	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs11819148	chr10:54783054-54783055	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs552478914	chr10:54783071-54783072	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs372760223	chr10:54783084-54783085	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs118051019	chr10:54783109-54783110	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs80090265	chr10:54783133-54783134	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs72800369	chr10:54783140-54783141	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs568551623	chr10:54783141-54783142	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs538314036	chr10:54783159-54783160	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs11812875	chr10:54783189-54783190	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs77235889	chr10:54783190-54783191	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs188524747	chr10:54783216-54783217	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs28865980	chr10:54783226-54783227	Enhancers Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs558855464	chr10:54783236-54783237	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs575448200	chr10:54783239-54783240	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs113420298	chr10:54783244-54783245	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs73349818	chr10:54783246-54783247	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs554424914	chr10:54783265-54783266	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs561793667	chr10:54783266-54783267	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs373624564	chr10:54783289-54783290	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs539910653	chr10:54783325-54783326	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs559794148	chr10:54783355-54783356	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Obesity	21956041	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Intellectual disability	21948486	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Metanephric adenoma	20802469	CNVD
Autism	20841430	CNVD
Mental retardation	17124404	CNVD
Epilepsy	20923578	CNVD
Prostate cancer	16573809	CNVD
Schizophrenia	19329560	CNVD
Heart failure	18772530	CNVD
Heart failure	18854381	CNVD
Hyperglycemia	19060297	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Glioblastoma multiforme	22286061	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Usher syndrome	20538994	CNVD
Glioblastoma multiforme	17002787	CNVD
Colorectal cancer	16774939	CNVD
Autism	20858243	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:234 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:54765200-54782600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr10:54782000-54783400	Enhancers	Monocytes-CD14+_RO01746	blood
3	chr10:54782000-54783600	Enhancers	iPS-15b Cell Line	embryonic stem cell
4	chr10:54782000-54783800	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr10:54782200-54782400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
6	chr10:54782200-54782400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
7	chr10:54782200-54782600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
8	chr10:54782200-54783000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
9	chr10:54782200-54783000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
10	chr10:54782200-54783200	Flanking Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr10:54782200-54783400	Enhancers	H1 Cell Line	embryonic stem cell
12	chr10:54782200-54783600	Enhancers	Placenta Amnion	Placenta Amnion
13	chr10:54782200-54784400	Enhancers	Fetal Kidney	kidney
14	chr10:54782400-54782600	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr10:54782400-54782600	Enhancers	iPS-20b Cell Line	embryonic stem cell
16	chr10:54782400-54782800	Weak transcription	Lung	lung
17	chr10:54782400-54783000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr10:54782400-54783400	Enhancers	Primary monocytes fromperipheralblood	blood
19	chr10:54782400-54783600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr10:54782400-54784000	Enhancers	Placenta	Placenta
21	chr10:54782400-54786000	Enhancers	Fetal Stomach	stomach
22	chr10:54782600-54782800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
23	chr10:54782600-54783000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr10:54782600-54783000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr10:54782600-54783000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
26	chr10:54782600-54783000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr10:54782600-54783200	Enhancers	Stomach Mucosa	stomach
28	chr10:54782600-54783400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr10:54782600-54783400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr10:54782600-54783600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr10:54782600-54783600	Enhancers	H9 Cell Line	embryonic stem cell
32	chr10:54782600-54783600	Enhancers	HUES64 Cell Line	embryonic stem cell
33	chr10:54782600-54783600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr10:54782600-54783600	Enhancers	NHEK	skin
35	chr10:54782800-54783600	Enhancers	Fetal Intestine Small	intestine
36	chr10:54782800-54783600	Enhancers	Fetal Lung	lung
37	chr10:54782800-54783800	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr10:54783000-54783200	Enhancers	Ovary	ovary
39	chr10:54783000-54783400	Enhancers	iPS-20b Cell Line	embryonic stem cell
40	chr10:54783000-54783600	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr10:54783000-54783600	Enhancers	HUES6 Cell Line	embryonic stem cell
42	chr10:54783200-54783400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr10:54783200-54784400	Weak transcription	Ovary	ovary
44	chr10:54783200-54784800	Weak transcription	Stomach Mucosa	stomach
45	chr10:54783400-54784400	Weak transcription	Primary monocytes fromperipheralblood	blood
46	chr10:54783400-54784600	Weak transcription	Monocytes-CD14+_RO01746	blood
47	chr10:54783400-54789200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr10:54783600-54784400	Weak transcription	Fetal Lung	lung
49	chr10:54783600-54784600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr10:54783600-54784600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links